Goldman's Top 50 Weak Balance Sheet Stocks
Goldman Sachs analysts listed 50 stocks constituents of their “weak balance sheet” basket.
Is There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 46% Undervaluation?
Jefferies Adjusts Price Target on Baxter International to $43 From $45
Baxter International (BAX) has an average rating of outperform and price targets ranging from $39 to $67, according to analysts polled by Capital IQ. Price: 37.34, Change: +0.43, Percent Change: +1.16
Decoding Baxter International Inc (BAX): A Strategic SWOT Insight
Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?
Thursday, Baxter International Inc (NYSE:BAX) reported first-quarter adjusted EPS of $0.65, up 10% Y/Y, beating the consensus of $0.61 and the management guidance of $0.59-$0.62.The company reported s
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Baxter International Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target price of
Stifel Adjusts Baxter International's Price Target to $44 From $50
Baxter International (BAX) has an average rating of outperform and price targets ranging from $39 to $67, according to analysts polled by Capital IQ. Price: 36.81, Change: -3.53, Percent Change: -8.75
Earnings Call Summary | Baxter International Inc(BAX.US) Q1 2024 Earnings Conference
The following is a summary of the Baxter International Inc. (BAX) Q1 2024 Earnings Call Transcript:Financial Performance:Baxter International reported Q1 sales from continuing operations of $3.6 billi
Baxter International Shares Are Trading Lower Following Soft Q2 EPS Guidance.
Baxter International Shares Are Trading Lower Following Soft Q2 EPS Guidance.
Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
Baxter International Inc. Q1 Profit Decreases, but Beats Estimates
Baxter International: No Final Decision Made on Separation Structure >BAX
Baxter International: No Final Decision Made on Separation Structure >BAX
Baxter International Expects Separation of Kidney-Care Business to Occur in 2nd Half >BAX
Baxter International Expects Separation of Kidney-Care Business to Occur in 2nd Half >BAX
Baxter International Sees 2024 Sales Up About 2%, Or 2%-3% Constant Currency >BAX
Baxter International Sees 2024 Sales Up About 2%, Or 2%-3% Constant Currency >BAX
Baxter International: Preparations Continue for Proposed Separation of Kidney-Care Segment >BAX
Baxter International: Preparations Continue for Proposed Separation of Kidney-Care Segment >BAX
Baxter International Sees FY24 Adj. EPS $2.88-$2.98 Vs $2.90 Est.
Baxter International Sees FY24 Adj. EPS $2.88-$2.98 Vs $2.90 Est.
Baxter Intl (BAX.US): The 2024 Q1 financial report achieved revenue of US$3,592 billion, with a previous value of US$3,649 billion, with an expected value of US$3.55 billion; earnings per share were US$0.65, previously $0.59, and an expected value of US$0
Baxter Intl (BAX.US): The 2024 Q1 financial report achieved revenue of US$3,592 billion, with a previous value of US$3,649 billion, with an expected value of US$3.55 billion; earnings per share were US$0.65, previously $0.59, and an expected value of US$0.61.
GUIDANCE: (BAX) BAXTER INTERNATIONAL Forecasts Q2 Adjusted EPS Range $0.65 - $0.67
07:19 AM EDT, 05/02/2024 (MT Newswires) -- GUIDANCE: (BAX) BAXTER INTERNATIONAL Forecasts Q2 Adjusted EPS Range $0.65 - $0.67
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Revenue $3.59B
07:16 AM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Revenue $3.59B
No Data